In silico perturbation of drug targets in pan-cancer analysis combining multiple networks and pathways

Claudia Cava1, Isabella Castiglioni1

  • 1Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Via F.Cervi 93, 20090 Segrate, Milan, Italy.

Gene
|March 7, 2019
PubMed

Insights

This study presents a computational method to analyze gene networks for predicting cancer drug efficacy. The approach identifies key gene networks crucial for classifying cancer versus normal samples and evaluating drug effects.

Area of Science:

  • Computational biology
  • Genomics
  • Cancer research

Background:

  • Predicting cancer therapy efficacy is critical for patient treatment.
  • A lack of specific biological markers hinders accurate prediction of treatment success.
  • Understanding cancer cell response to therapy is essential.

Purpose of the Study:

  • To optimize a computational method for analyzing gene networks.
  • To detect and quantify drug effects in a pan-cancer study.
  • To identify key gene networks involved in cancer biology.

Main Methods:

  • Utilized network topological measures for gene network analysis.
  • Developed a computational model for in silico drug modulation.
  • Applied the method to a pan-cancer dataset.

Main Results:

  • Identified a significant cancer gene network with a key role in biological processes.
  • The gene network effectively classified cancer versus normal samples.
  • The model evaluated the effects of approved and novel drugs in silico.

Conclusions:

  • The computational model aids in deciphering molecular mechanisms of drug resistance.
  • This approach offers insights into drug inefficacy.
  • The method provides a valuable tool for predicting cancer drug response.

Related Concept Videos

Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
156
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.3K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.8K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.7K